NASDAQ: TELO
Telomir Pharmaceuticals Inc Stock Ownership - Who owns Telomir Pharmaceuticals?

Insider buying vs selling

Have Telomir Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Erez AminovCEO and Chairman2024-08-19200$6.01
$1.20kSell
Erez AminovCEO and Chairman2024-08-19200$6.20
$1.24kSell

1 of 1

TELO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TELO insiders and whales buy or sell their stock.

TELO Shareholders

What type of owners hold Telomir Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shore Trust Bay11.06%3,292,696$4.18MInsider
Vanguard Group Inc4.23%1,258,190$1.60MInstitution
Blackrock Inc4.03%1,200,561$1.52MInstitution
Christopher C. Chapman Jr.3.28%975,610$1.24MInsider
Craig Eagle1.64%487,805$619.51kInsider
Geode Capital Management LLC1.44%429,252$545.15kInstitution
Northern Trust Corp0.52%154,072$195.67kInstitution
State Street Corp0.42%125,673$159.60kInstitution
Nathen Fuentes0.34%101,134$128.44kInsider
Bank Of New York Mellon Corp0.31%91,353$116.02kInstitution

1 of 3

TELO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TELO12.41%16.99%Net Selling
MRSN33.53%66.47%Net Selling
IPA11.97%0.00%
CLNN1.16%98.84%Net BuyingNet Selling
PYPD24.97%0.00%

Telomir Pharmaceuticals Stock Ownership FAQ

Who owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals (NASDAQ: TELO) is owned by 12.41% institutional shareholders, 16.99% Telomir Pharmaceuticals insiders, and 70.60% retail investors. Shore Trust Bay is the largest individual Telomir Pharmaceuticals shareholder, owning 3.29M shares representing 11.06% of the company. Shore Trust Bay's Telomir Pharmaceuticals shares are currently valued at $3.89M.

If you're new to stock investing, here's how to buy Telomir Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.